The RB1CC1 gene helps cells grow normally and clear out damaged parts through a recycling process that is especially important in the brain. If this gene does not work properly, cells may struggle to stay healthy, which can affect early brain development. People with pathogenic variants in the RB1CC1 gene may have developmental delay, intellectual disability, low muscle tone, seizures, or problems with movement and balance. This is not a gene that has become widely known in popular culture.
What is a gene?
A gene is a stretch of DNA that carries instructions cells use to make molecules or regulate activities in the body. Some genes provide the directions for producing proteins, which do much of the cell’s work. Others are mainly involved in controlling when a process happens, where it happens, and how active it is. Taken together, genes affect how the body grows and works, and they can influence how you respond to food, stress, and medicines. For a deeper look at this topic, visit the LearnHub.
Overview
RB1CC1Gene function
What if the gene works
The RB1CC1 gene helps cells start autophagy, a recycling process that clears damaged parts. It also supports cell growth control and survival, especially when cells are under stress.
Risk
What if the gene does not work
Changes in the RB1CC1 gene can disrupt brain development and cell cleanup pathways. More severe variants are linked to developmental delay or intellectual disability, sometimes with seizures or brain structure differences, while milder variants may cause later-onset movement problems.
Treatment
What does that mean for your treatment
No treatment or management approach is currently tailored specifically to pathogenic variants in the RB1CC1 gene. The RB1CC1 gene is being studied in cancer and brain research because it helps control a cell recycling process, so it may become a biomarker or drug target in the future.
Gene function
What if the gene works
Your cells need the RB1CC1 gene for routine cleanup and balance. It helps launch autophagy, the process behind how cells recycle old parts and reuse useful building blocks. It also helps bring together the proteins that start this process at the right time.
The RB1CC1 gene helps start autophagy (your cells' recycling process). This allows old or unneeded cell material to be collected, broken down, and reused.
Its protein acts like an assembly platform for other recycling proteins. This helps the recycling process begin in an organized, well timed way.
The RB1CC1 gene also helps connect recycling to signals about nutrient and energy supply. This helps cells adjust internal cleanup to everyday needs.
What is a variant?
A genetic variant is a small change in the DNA sequence of a gene. These changes are common and help account for normal human diversity, such as differences in appearance, metabolism, or how the body responds to environmental influences. Many variants do not have any noticeable effect and simply represent natural genetic variation. In some cases, though, a variant can change how a gene functions more substantially and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the RB1CC1 gene can change the size, shape, or stability of the FIP200 protein, so RB1CC1 gene variants affect protein function by weakening contacts with partner proteins and disrupting autophagy (the cell's recycling system). Milder variants may leave some activity in place, while more disruptive variants can reduce function much more or leave little or no usable protein. In people with conditions linked to the RB1CC1 gene, larger functional losses are often tied to earlier or more noticeable features.
How variants are linked to conditions
Pathogenic variants in the RB1CC1 gene can cause a rare RB1CC1-related neurodevelopmental condition. Reported features include developmental delay or intellectual disability, low muscle tone, balance or movement problems, and changes seen on brain MRI. In this setting, finding a disease-causing RB1CC1 variant can help confirm the diagnosis.
A variant is not necessarily a diagnosis
Genetic variants are a normal feature of human biology and are common in the general population. Most have no direct effect on health and simply contribute to natural human diversity. For many genes, carrying a variant associated with a condition indicates a possible link rather than a definite diagnosis, especially when more than one gene and environmental factors are involved. In some cases, though, a single well-characterized variant in a particular gene can be enough to confirm a diagnosis.
Are there things that can increase or change my risk?
There isn't yet broadly confirmed evidence on specific factors that increase or reduce health risk related to RB1CC1. If a change in RB1CC1 has been found, the main driver of risk is usually the genetic change itself, and a doctor or genetic counselor can help explain what that may mean for you or your family.
Inheritance of RB1CC1 variants
For the condition currently linked to the RB1CC1 gene, the RB1CC1 gene inheritance pattern is autosomal dominant. This means a person only needs one disease causing variant in the RB1CC1 gene to have the condition, and each child of an affected parent has a 50% chance of inheriting that variant. Some people have a new, de novo variant in the RB1CC1 gene, which means it started in them and was not inherited from either parent.
What does my RB1CC1 result mean for my family?
There is not yet a broadly confirmed inheritance pattern tied to a specific condition for RB1CC1. If you have a specific RB1CC1 result and want to understand what it could mean for parents, children, brothers, sisters, or future pregnancies, a doctor or genetic counselor can explain it in the context of your exact result and family history.
Genetic information
Genetic testing
How you find out about variants
Testing for variants in the RB1CC1 gene usually uses a blood or saliva sample. An RB1CC1 genetic test examines your DNA for changes, and results may show a variant known to affect health, a variant of uncertain significance, or no relevant variant.
When should I consider getting a genetic test?
Genetic testing may be worth considering if someone has unexplained delays in development, learning, or speech, movement or balance problems, or unusual findings on a brain scan, especially if similar features run in the family. RB1CC1 is often looked at as part of a broader genetic test rather than as a single-gene test.
A genetic result is only one part of your health story
A genetic result can be informative, but what it can tell you varies with the condition and the kind of variant involved. Over time, the way the body works is shaped by many factors, including lifestyle, environment, age, and medical history. For some conditions, especially those influenced by many genes, genetic information provides context rather than certainty and is best understood together with other parts of care. In other situations, a genetic result may offer a clear answer. In areas like medication response, genetic results can also help put personal experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Small differences in DNA can change how the body breaks down a drug, moves it through the bloodstream, or responds to it at its target. This helps explain why the same medication may work well for one person, cause more side effects in another, or seem less effective in someone else. These differences are common and are one reason treatment response can vary from person to person.
What is Pharmacogenetics?
Pharmacogenetics examines how genetic differences can shape a person’s response to medications. It studies links between genes and drugs to help explain why the same treatment may work differently from one person to another. For many medicines, genes affect either how strongly a drug works or how the body handles it. This information can support treatment decisions that are both more informed and more individualized. You can read more about this topic in the LearnHub.
Drugs influenced by the RB1CC1 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding medication choices. If you have concerns about side effects, a medicine not working as expected, or changes to your treatment, talk with your doctor or pharmacist.
History
Researchers first described the RB1CC1 gene in the late 1990s while studying proteins linked to cell growth control. Soon after, it was also identified as FIP200 in work exploring how cells respond to signals that regulate survival and stress. From these first observations, research expanded steadily, and RB1CC1 became better known through studies connecting it to broader cell biology pathways. In the 2000s and 2010s, laboratory research placed the RB1CC1 gene within major networks that had become important across cancer and autophagy research. Over time, scientists’ understanding of the gene’s role has changed as its place in these pathways became clearer.